Pharmaceutical Executive-05-07-2009

Pharmaceutical Executive

Amylin Drops 200 Sales Reps

May 07, 2009

News Analysis

0

0

As it readies submission for a once-weekly diabetes injectable, Amylin announces that it will trim 35 percent of its sales force and put focus on specialty physicians.

Rx Scripts Spike in Wake of Swine Flu

May 07, 2009

News Analysis

0

0

New prescriptions for antiviral treatments get huge boost due to H1N1 epidemic. Numbers exceed those seen during this year's influenza season, and the numbers are climbing.

Bio Companies Low on Venture Capital Cash

May 06, 2009

News Analysis

0

0

As the economy continues to retract, fewer biotech companies are finding the funding they need to survive, driving more firms to sell or close shop.

Reading the "Risk Radar"

May 06, 2009

News Analysis

0

0

Pharm Exec Europe's Gerhard Symons speaks to Andrew Jones, a senior pharmaceutical analyst with the firm, about the value of introducing a "risk radar" to your organization.